Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Vera’s dual-target atacicept wins FDA approval for IgAN
While atacicept is the first BAFF/APRIL dual inhibitor to enter the U.S. market, Vertex's povetacicept is trailing closely.
Angus Liu
Jul 7, 2026 12:23pm
Novartis dismisses 322 more staffers based out of US headquarters
Jul 7, 2026 11:41am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
BMS details Krazati confirmatory fail in colorectal cancer
Jul 7, 2026 10:46am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
Regulatory tracker: AbbVie, Genmab's bispecific wins EU expansion
Jul 7, 2026 10:15am
